Christopher White
@ChrisMedTech
Followers
627
Following
2K
Media
543
Statuses
2K
Cyclist|beekeeper|Annapolitan|sailer. AdvaMed's GC & CPO, but all tweets are mine. Mostly professional, but can't resist proud dad & Wake Forest shoutouts.
Washington, DC
Joined January 2011
It was an honor to join @CommerceGov DAS Western Hem Ian Saunders and Brazil CGU to discuss public private partnership to advance Ethical Biz Practices Across the Americas in conjunction with #Summit of Americas. @AdvaMedUpdate
2
1
8
Litigation Financing puts patients at risk + chills innovation--my blog describes why. We'll explore this trend in expert legal panels next week at #MedTechCon. @advamedupdate
advamed.org
On September 13th, 2023, the U.S. House Oversight Committee held a hearing on the impact of third-party litigation financing, an issue of significant concern to AdvaMed® and its members. Third-party...
0
1
4
Interested in #medtech? This deserves top position on your playlist! Better yet--join our conference in LA next week and meet with medtech leaders convening with @advamedupdate
podcasts.apple.com
Podcast Episode · Medtech POV with Scott Whitaker · 09/28/2023 · 12m
0
0
1
Interested in #medtech? This deserves top position on your playlist! Better yet--join medtech leaders convening in LA next week for #MedtechCon. @AdvaMedUpdate
podcasts.apple.com
Podcast Episode · Medtech POV with Scott Whitaker · 09/28/2023 · 12m
0
1
2
ICYMI: AdvaMed's comments on third-party litigation funding were read into the record during a House Oversight Committee hearing last week. Read the full letter: https://t.co/2gSxgZPVdQ
Third-party litigation funding threatens to undermine our health care system and put patients at risk, @ChrisMedTech writes in a letter to @GOPOversight and @oversightdems. Read more from @AdvaMedUpdate’s Chief Policy Officer:
0
1
5
Ever wonder why you see so many legal ads? Hidden financiers subsidize ads to spur litigation. When that happens, patients are at risk. @AdvaMedUpdate
Third-party litigation funding threatens to undermine our health care system and put patients at risk, @ChrisMedTech writes in a letter to @GOPOversight and @oversightdems. Read more from @AdvaMedUpdate’s Chief Policy Officer:
0
1
4
Looking forward to @PavMedInc/@LucidDiag CEO and member of the AdvaMed Board Dr. Lishan Aklog’s testimony before the House E&C health subcommittee today on the need for Congress to pass #TCET legislation. 1/
1
9
15
My view from the podium. Thanks @MedmarcIns for convening medtech summit & support of @AdvaMedUpdate Frivolous litigation corrodes innovation and impedes patient access to lifesaving technologies.
0
2
7
Thank you @MedmarcIns for long-standing support of medtech and patients everywhere. Honored to present at your medtech leadership meetings today. @AdvaMedUpdate
0
1
4
I'm so proud to work with leaders such as those featured here, committed to ethics, patients and medical innovation. Join us in celebrating 30 years of medtech's compass, navigating innovation for patients everywhere. @AdvaMedUpdate
0
3
6
Yikes! Investor-driven litigation — patients beware! See my blog on this concerning trend. @advamedupdate
advamed.org
Chris White, AdvaMed®'s General Counsel, explores the GAO's recent report as "a welcome independent review raising attention to the need for disclosure and regulation of the litigation financing that...
0
0
1
AdvaMed’s General Counsel and Chief Policy Officer, Chris White, explains why the Federal Trade Commission’s proposed rule on non-compete agreements could hurt patients. https://t.co/pMo0dIDMOa
#patientaccess #medtech
advamed.org
The Federal Trade Commission published a proposed rule in the Federal Register that would, among other things, prohibit employers from imposing non-compete agreements on their employees.
1
3
8
Thanks to my @advamedupdate colleague Ida Nassar for leading our legal policy work on FTC's overbroad noncompete rulemaking. See my blog here: FTC’s Non-Compete Agreement Rulemaking Puts Medtech Innovation and Patient Access to New Treatments at Risk
linkedin.com
Thanks to my AdvaMed legal colleague Ida Nassar for leading our legal policy work on this important issue. Patients everywhere depend on America's innovative medtech industry, and the predictable...
0
0
0
Great talk from Former Federal Reserve Vice Chair Roger Ferguson at the #CEOSummit this morning. “If I were 25 and could do it over again, I would choose a career in medtech…”
0
5
10
.@JNJMedtech’s Ashley McEvoy has a long history of leadership in the medtech industry, and it has prepared her well to lead our AdvaMed Board as Chair. I look forward to working with her and the Board on behalf of the patients we serve.
0
5
10
Very cool opportunity to speak with @HamlinIsland at our CEO Summit. What an inspirational guy, on and off the field. Disciplined. Entrepreneurial. Humble. Thanks for joining us and for inspiring our entire country with your amazing recovery, Damar.
1
2
16
#News: Today @AdvaMedUpdate announced that Ashley McEvoy, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, was elected Chair of the AdvaMed Board of Directors. Read more: https://t.co/0p7mr7qB0I
#JNJMedTechProud
3
15
30
Glad to be working with AdvaMed to help improve patient access and care of life saving medical devices.
Every Congress & every Administration talks about the importance of driving medical innovation & increasing patient access to care. So we created a policy blueprint to help them accomplish exactly that. Let’s get to work on this list, starting today:
0
4
5
Every Congress & every Administration talks about the importance of driving medical innovation & increasing patient access to care. So we created a policy blueprint to help them accomplish exactly that. Let’s get to work on this list, starting today:
0
5
7
Packed house as #medtech compliance leaders convene for @AdvaMedUpdate compliance meetings. Thank you @JNJInnovation @JNJNews for hosting!
0
2
2
Thank you @JNJInnovation @JNJNews for hosting @AdvaMedUpdate compliance leaders today! Committed to patients and Ethics!
0
2
4